AI-Native Scoping Reviews & Evidence Mapping

Fast food is more than a convenient meal—it is a recurring marker of poorer diet quality, obesity, cardiometabolic risk, mental-health symptoms, sleep disruption, and environmental exposure across diverse populations. Drawing on 735 references and 1,469 original studies, the full review reveals where the evidence is strongest, which risks are most consistent, and which interventions may offer the greatest real-world impact.

Climacteric symptoms extend far beyond hot flushes, affecting sleep, mood, cognition, sexual health, work ability, and overall quality of life across the menopausal transition. The full review reveals which hormonal, non-hormonal, botanical, behavioral, and device-based treatments show the most meaningful benefits—and how treatment should be matched to each woman’s symptoms, risks, and clinical context.

Single-parent family status is not a deterministic risk factor, but it repeatedly signals where children and caregivers may face greater pressure across mental health, chronic illness management, healthcare access, socioeconomic disadvantage, and health-risk behaviors. The full review reveals which risks are most consistent, which family and social supports can buffer them, and where interventions should be tailored rather than generalized.

Benign prostatic hyperplasia may be driven as much by metabolic dysfunction, inflammation, frailty, and lifestyle as by the prostate itself. This review maps the strongest human and experimental evidence—from HDL and fatty liver disease to immune markers, microbiome pathways, and emerging preventive targets—making the full read valuable for anyone seeking the complete prevention landscape.

Multilingual children are often assessed and educated inside systems built around monolingual norms, creating real risks of misdiagnosis, lost heritage-language potential, and unequal educational support. This review shows where multilingualism becomes a clinical challenge, an educational resource, and a misunderstood developmental advantage worth reading in full.

Falsified and substandard medicines are not a marginal pharmacy problem — they are a global public-health threat spanning antimalarials, antibiotics, anticancer agents, cardiovascular drugs, online semaglutide, benzodiazepines, supplements, and emerging synthetic opioids. Unlock the full review to explore 75 mapped references, 103 original studies, prevalence signals up to 59.5%, toxic contamination risks, detection technologies, and the supply-chain gaps that still leave patients exposed.

Pornography is not a single-risk exposure but a complex behavioral ecosystem where most users report neutral or positive effects, while a clinically important minority develop problematic use linked to mental distress, relationship conflict, risky sexual behavior, and aggression-related outcomes. The full read maps 318 references across 1,287 original studies, separating frequency from problematic use and showing where pornography literacy, couple context, moral incongruence, and targeted screening may actually matter.

Surgery does not end when the operation ends: this review shows that across oncology, bariatrics, orthopedics, transplantation, and vascular care, postoperative medication adherence is often the hidden determinant of recurrence, complications, and survival. The full read is worth it because it separates where adherence reliably fails, which barriers drive that failure, and which interventions actually help keep patients on treatment after discharge.

Falsified medical products are not a niche drug-safety problem, but a supply-chain failure spanning medicines, devices, online pharmacies, informal markets, and weak regulatory systems. The full evidence map shows where risk concentrates — from semaglutide and PDE-5 products to vaccines, antibiotics, devices, and digital marketplaces — and which detection, reporting, and regulatory tools can realistically close the gaps.